Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GLMD

Galmed

$8.16

0.32 (4.08%)

07:55
03/13/19
03/13
07:55
03/13/19
07:55
Conference/Events
Galmed to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

GLMD

Galmed

$8.16

0.32 (4.08%)

07:05
03/13/19
03/13
07:05
03/13/19
07:05
Earnings
Breaking Earnings news story on Galmed »

Galmed reports Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

GLMD

Galmed

$8.16

0.32 (4.08%)

04:55
03/13/19
03/13
04:55
03/13/19
04:55
Conference/Events
Galmed to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

GLMD

Galmed

$7.84

0.25 (3.29%)

08:02
03/12/19
03/12
08:02
03/12/19
08:02
Hot Stocks
Galmed announces results from pharmacokinetic study of Aramchol »

Galmed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

GLMD

Galmed

$7.59

-0.09 (-1.17%)

15:07
03/10/19
03/10
15:07
03/10/19
15:07
Conference/Events
Galmed to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

Over a month ago
GLMD

Galmed

$8.71

-0.18 (-2.02%)

07:43
01/14/19
01/14
07:43
01/14/19
07:43
Recommendations
Galmed analyst commentary at H.C. Wainwright »

Galmed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
FOMX

Foamix

$4.08

0.27 (7.09%)

, JAZZ

Jazz Pharmaceuticals

$142.70

2.24 (1.59%)

10:37
12/12/18
12/12
10:37
12/12/18
10:37
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

FOMX

Foamix

$4.08

0.27 (7.09%)

JAZZ

Jazz Pharmaceuticals

$142.70

2.24 (1.59%)

GWPH

GW Pharmaceuticals

$125.00

2 (1.63%)

SIX

Six Flags

$60.80

2.4 (4.11%)

IQ

iQIYI

$18.28

0.26 (1.44%)

ICPT

Intercept

$109.66

4.93 (4.71%)

VKTX

Viking Therapeutics

$9.60

0.13 (1.37%)

MDGL

Madrigal Pharmaceuticals

$111.91

-2.78 (-2.42%)

GLMD

Galmed

$8.67

0.735 (9.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

GLMD

Galmed

$7.94

-0.445 (-5.31%)

, ICPT

Intercept

$104.73

-1.32 (-1.24%)

09:02
12/12/18
12/12
09:02
12/12/18
09:02
Initiation
Galmed, Intercept, Viking Therapeutics, Madrigal Pharmaceuticals initiated at B. Riley FBR »

B. Riley FBR rolls out…

GLMD

Galmed

$7.94

-0.445 (-5.31%)

ICPT

Intercept

$104.73

-1.32 (-1.24%)

VKTX

Viking Therapeutics

$9.47

0.01 (0.11%)

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$7.94

-0.445 (-5.31%)

17:18
12/11/18
12/11
17:18
12/11/18
17:18
Initiation
Galmed initiated at B. Riley FBR »

Galmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$132.96

3.49 (2.70%)

, VKTX

Viking Therapeutics

$12.05

0.4 (3.43%)

11:01
11/19/18
11/19
11:01
11/19/18
11:01
On The Fly
Street Fight: Analysts diverge on NASH drug makers following AASLD »

This morning, Raymond…

MDGL

Madrigal Pharmaceuticals

$132.96

3.49 (2.70%)

VKTX

Viking Therapeutics

$12.05

0.4 (3.43%)

ICPT

Intercept

$102.77

0.17 (0.17%)

GLMD

Galmed

$8.50

-0.21 (-2.41%)

GNFTF

Genfit

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.